The purpose of this study was to compare the physical activity and caloric intake trends of lipid-lowering drug users with those of non-users among Korean adults with dyslipidemia. Methods: This study was a repeated cross-sectional study with a nationally representative sample of 2,635 Korean adults with dyslipidemia based on the 2010-2013 Korea National Health and Nutrition Examination Survey. Physical activity was assessed using the International Physical Activity Questionnaire, and caloric intake was estimated through 24-hour dietary recall. All statistical analyses were conducted using IBM SPSS ver. 21.0 (IBM Co., Armonk, NY, USA). The changes in physical activity and caloric intake were investigated for lipid-lowering drug users and non-users using generalized linear models. Results: The proportion of lipid-lowering drug users in the 2010-2013 survey population increased from 3.5% to 5.0% (P<0.001). Among adults of dyslipidemia, total of 1,562 participants (56.6%) reported taking lipid-lowering drugs, and 1,073 (43.4%) reported not taking lipid-lowering drugs. Drug users were more likely to be older and less educated and to have a diagnosis of diabetes, higher body mass index, and lower low density lipoprotein cholesterol level. Physical activity trends were tested separately for the lipid-lowering drug users and non-users, and a significant decrease was found among the drug users during the study period. Physical activity among the drug users in 2013 was 38% lower (1,357.3±382.7 metabolic equivalent [MET]; P for trend=0.002) than in 2010 (2,201.4±442.6 MET). In contrast, there was no statistically significant difference between drug users and non-users in the trend of caloric intake during the same period. Conclusion: Physical activity significantly decreased among lipid-lowering drug users between 2010 and 2013, which was not observed among non-users. The importance of physical activity may need to be re-emphasized for lipid-lowering drug users.
INTRODUCTION
Dyslipidemia is a major risk factor for cardiovascular disease; total cholesterol, low density lipoprotein cholesterol (LDLC), and triglyceride levels are directly proportional to the risk of cardiovascular mortality. 1) Thus, management of blood cholesterol is important to prevent cardiovascular disease.
The American College of Cardiology and the American Heart Association (ACC-AHA) and the National Institute for Health and Care Excellence guidelines for the treatment of blood cholesterol emphasized the importance of dietary changes and regular physical activity as the first line of management for dyslipidemia. [2] [3] [4] [5] In a randomized controlled pilot study, the National Cholesterol Education Program (NCEP) step 1 diet program reduced total cholesterol and LDLC levels by 5% and 13%, respectively, and the NCEP exercise program was associated with an increase in high density lipoprotein cholesterol level.
6)
The use of lipid-lowering drugs has rapidly increased in Korea and the United States, 7, 8) and implementing the 2013 guidelines of the ACC-AHA for the management of cholesterol would increase the number of US adults who would be eligible for statin use from 37.5% to 48.6%. 9) Furthermore, caloric and fat intake in Korean and US adults has increased over the past 10 years. 7, 10) Therefore, it is important to investigate the effects of dietary modification and physical activity on patients with dyslipidemia. In the early 2000s, a cross-sectional study, the Study of Exercise and Nutrition in Older Rhode Islanders Project,
showed that participants who reported taking lipid-lowering drugs had better lipid profiles and lower caloric intake than statin non-users, but no significant difference in physical activity was reported among study subjects. 11) A cross-sectional study in Sweden in 2004 investigated the perception of risk factors for cardiovascular disease among adults using statins, and found that statin users were more likely to avoid fatty foods and to eat foods with a high fiber content. 12) A crosssectional study using the data of the National Health and Nutrition Examination Survey (NHANES) conducted during 1999-2010 compared the trend of caloric and fat intake between statin users and non-users over time and found a significant increase in the caloric and fat intake of statin users. 13) To our knowledge, no studies have examined the cross-sectional relationship between physical activity and the use of lipid-lowering drugs among Korean adults with dyslipidemia. The purpose of the present study was to compare physical activity and caloric intake trends of lipid-lowering drug users with those of non-users among Korean adults with dyslipidemia.
METHODS

Data Sources and Participants
The Korea National Health and Nutrition Examination Survey 
Variables and Measurements
Subjects were considered to have dyslipidemia if they reported a diagnosis of dyslipidemia by a doctor in the health interview survey. We defined lipid-lowering drug users as participants with dyslipidemia who had been taking lipid-lowering drugs, and we categorized the subjects into two groups: lipid-lowering drug users and non-users.
Food intake was measured through 24-hour dietary recall in the KNHANES. The dietary questionnaire was administered during faceto-face interviews and included the type, amount, and frequency of foods or drinks consumed during the previous day.
Physical activity was assessed using the Korean version of the International Physical Activity Questionnaire (IPAQ). We extracted the data for sociodemographic characteristics including age, sex, level of education, and marital status. Subjects were classified into the following age groups: 20 to 39 years, 40 to 59 years, and 60 years or older. Level of education was classified into less than elementary school (≤6 years), less than high school graduation (≤12 years), or high school graduation or more (>12 years). 
Statistical Analysis
All statistical analyses were performed using IBM SPSS ver. 21.0 (IBM Co., Armonk, NY, USA). In order to represent the Korean population, stratified random sampling (kstrata), cluster sampling (psu), and sampling weights (wt_itvex) were used. Data analyses were performed to account for the complex sample design.
We analyzed the differences in categorical variables (such as level of education, marital status, alcohol intake, and smoking status) using chi-square tests and continuous variables (total cholesterol level and LDLC level) using t-tests in complex sample analysis. General linear models were used to estimate the trends of physical activity and caloric intake among Korean adults with dyslipidemia, after adjusting for sex, age group, level of education, marital status, BMI, and diagnosis of diabetes. P-values <0.05 were considered statistically significant.
RESULTS
In the 2010-2013 KNHANES, the weighted proportion of adults with dyslipidemia increased from 6.1% (2010) (Table 2 ).
There were significant differences between the two groups for the different variables we examined with the exception of smoking and marital status. The mean age of participants was 58.47±0.31 years; the average age of drug users was 61.08±0.36 years, which was significantly older than that of non-users (55.06±0.48 years, P<0.001).
Lipid-lowering drug users were more likely to be older, female, and less educated, and to have a diagnosis of diabetes, higher BMI, and lower LDLC level. The BMI of drug users was 25.26±0.13 kg/m 2 , which was higher than that of non-users (24.84±0.12 kg/m 2 , P=0.024). Drug users had significantly lower levels of total cholesterol and LDLC than non-users (P<0.001).
In Table 3 and Figure 1 , adjusted for sex, age group, level of education, marital status, BMI, and diagnosis of diabetes, we examined the trends of physical activity and caloric intake separately for lipid-lowering drug users and non-users by year in the 2010-2013 study period. and fat intake over time until it was higher than in statin non-users.
13)
These results correspond with our findings that dietary modifications were not observed. In the Rhode Island cross-sectional study during the early 2000s, the caloric intake of statin users among adults older than 60 was lower than in statin non-users. 11) The cross-sectional study in Sweden in 2004 showed statin users consumed higher-fat foods than statin non-users. 12) This appears to corroborate the aforesaid report that caloric intake of statin users was lower than in the statin nonusers in the NHANES during the early 2000s. A cohort study in primary care clinics in the US examined patients who received their first prescription for statins in 2005. These researchers found that 76% of the participants wanted to reduce dietary fat intake; however, no significant change in caloric and fat intake was reported during the 6-month observation period. 17) This study had the advantage of being a longitudinal cohort study in which causal relationships may be inferred, but the 71-participant sample size was too small and the observation period of 6 months was too short to confirm the behavioral change associ- ated with statin use. We examined the trends of physical activity and caloric intake through a nationwide cross-sectional study using the KNHANES.
In the guidelines of blood cholesterol management, lifestyle modification is a key component of controlling blood cholesterol and preventing cardiovascular disease. [2] [3] [4] [5] A decrease in physical activity and higher BMI among statin users compared to non-users shows that lifestyle management among lipid-lowering drug users is not satisfactory.
There are three possible hypotheses to explain these results. First, the improved levels of total cholesterol and LDLC after taking lipid-lowering drugs could weaken patients' motivation to follow the recommended physical activity program. Second, patients who are unwilling to make lifestyle changes may prefer to take lipid-lowering drugs, while physically active patients may prefer not to take the drugs. Third, recent dyslipidemia guidelines emphasize pharmacological treatment; thus, patient education regarding lifestyle modifications could be weak. 13) This study had several limitations. Physical activity and caloric intake data were obtained through the self-report questionnaires used in the KNHANES; thus, there is a risk of self-report bias. In addition, elderly patients may have difficulty remembering their physical activities and food intake. However, the reliability and validity of the IPAQ were proven in 14 centers from 12 countries. 14, 15) The second limitation is that the questionnaire used in the KNHANES investigated only whether patients were taking any lipid-lowering drugs, not the specific drug ingredients. Third, this study is a repeated cross-sectional study rather than a cohort study; thus, the participants differed during each study period. 13 ) Even though we cannot infer that the physical activity of individual study participants decreased over time, the nationally representative surveillance data of the KNHANES was a strength of this study.
This study found a statistically significant decrease in the physical Values are presented as % or mean±standard deviation. NA, not applicable. *Calculated using chi-square tests for categorical variables and t-tests for continuous variables in complex sample analysis. † Calculated as weight in kilograms divided by height in meters squared. activity of Korean patients who reported taking lipid-lowering drugs, which was not observed among the non-users during the 2010-2013 study period. Based on this result, we suggest that the implementation of lifestyle modifications is insufficient. Physicians should stress the importance of physical activity along with lipid-lowering drugs for lipid-lowering drug users. In addition, pharmacological therapy for the treatment of cardiovascular and chronic disease is increasing; thus, future studies examining the association between taking drugs and lifestyle modification may be needed.
